Related Experiment Videos
Gene therapy in the neuroendocrine system: its implementation in experimental models using viral vectors
1Institute for Biochemical Research of La Plata (INIBIOLP) - Histology 'B', Faculty of Medicine, National University of La Plata, Argentina.
Neuroendocrinology
|March 13, 2001
Summary
Gene therapy shows promise for neuroendocrine disorders, utilizing viral vectors like adenoviruses and HSV-1. Research in animal models targets pituitary tumors and diabetes insipidus, with potential for neurodegenerative diseases.
Area of Science:
- Neuroendocrinology
- Genetics
- Molecular Biology
Background:
- Gene therapy is rapidly advancing for therapeutic genetic material transfer.
- Neuroendocrine system applications are emerging, showing promising research results.
- Viral vector-based gene delivery is key in neuroendocrinology research.
Purpose of the Study:
- To review viral vector systems (adenoviral, HSV-1) for neuroendocrine gene therapy.
- To provide an update on neuroendocrine pathologies targeted by gene therapy in animal models.
- To outline gene therapy's potential in age-associated neuroendocrine neurodegeneration.
Main Methods:
- Utilizing adenoviral vectors for suicide gene therapy (HSV-1 thymidine kinase) against pituitary tumors.
- Employing adenoviral vectors encoding the human retinoblastoma suppressor oncogene.
- Using adenovirus vectors with arginine vasopressin cDNA to treat diabetes insipidus in rats.
Main Results:
- Successful treatment of experimental pituitary tumors using a suicide gene approach.
- Rescue of spontaneous pituitary tumor phenotypes in mice via retinoblastoma oncogene transfer.
- Correction of diabetes insipidus in rats for several weeks using arginine vasopressin gene therapy.
Conclusions:
- Gene therapy demonstrates potential for treating neuroendocrine pathologies, including tumors and diabetes insipidus.
- Further development of gene delivery systems is crucial for overcoming technical challenges.
- Gene therapy holds promise for addressing age-related neuroendocrine neurodegenerative processes.